Daegu, South Korea

Ja Wook Koo

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 21.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ja Wook Koo: Innovator in Pharmaceutical Composition

Introduction

Ja Wook Koo is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target protein kinase-related diseases. His innovative work has the potential to impact the treatment of various neurological conditions.

Latest Patents

Ja Wook Koo holds a patent for a pyrrolo-pyridine derivative compound, which includes a method for preparing the compound and a pharmaceutical composition that contains it as an active ingredient. This invention is particularly relevant for the prevention or treatment of protein kinase-related diseases. The compound exhibits excellent inhibitory activity against various protein kinases, including DYRK1A. Consequently, the pharmaceutical composition can be effectively utilized in the treatment or prevention of Alzheimer's disease, dementia, and Alzheimer's dementia.

Career Highlights

Throughout his career, Ja Wook Koo has been associated with prominent organizations such as the Daegu-Gyeongbuk Medical Innovation Foundation and the Korea Research Institute of Bioscience and Biotechnology. His work in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Ja Wook Koo has collaborated with several professionals in his field, including Hwan Geun Choi and Eunhwa Ko. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Ja Wook Koo's contributions to pharmaceutical innovation, particularly in the area of protein kinase-related diseases, highlight his role as a significant inventor. His work has the potential to lead to advancements in the treatment of critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…